225 Ac 3+ is a generator of α-particle-emitting radionuclides with 4 net α-particle decays that can be used therapeutically. Targeting 225 Ac 3+ by use of ligands conjugated to traditional bifunctional chelates limits the amount of 225 Ac 3+ that can be delivered. Ultrashort, single-walled carbon nanotubes (US-tubes), previously demonstrated as sequestering agents of trivalent lanthanide ions and small molecules, also successfully incorporate 225 Ac 3+ .
Single-walled carbon nanotubes (SWNTs, Fig. 1A ) are cylinder-shaped, "rolled-up" graphene sheets that possess a graphitic carbon exterior allowing for covalent functionalization with disease-targeting agents (1) (2) (3) (4) (5) . Moreover, when SWNTs are properly prepared (6) , they possess small defects along their sidewalls that allow for the encapsulation of small molecules and ions within their hollow interior (7) (8) (9) . These features render SWNTbased materials potentially useful as delivery platforms for targeted α-particle-emitting radionuclides, for radioimmunotherapy of cancer (10) (11) (12) . Here, we examine the ability of modified SWNTs (under 100 nm in length, known as ultrashort tubes [US-tubes], Fig. 1C ) to encapsulate the potent α-particle ( 4 He 2+ ) generator 225 Ac 3+ .
α-particle emitters, such as 213 Bi, 211 At, and 225 Ac, possess a far greater linear energy transfer (5,000-8,000 keV) and shorter range (50-80 μm, or a few cell diameters) than the β-particle (e − ) emitters currently used for radioimmunotherapy, such as the Food and Drug Administration-approved 90 Y and 131 I (8, 11, 13, 14) . These properties of α-particle emitters make them preferred for the specific killing of small-volume cancers such as single cells or micrometastatic lesions. Moreover, Monte Carlo simulations suggest that a solitary α particle can have a cytotoxic effect equivalent to that of over a thousand β particles (15) . 225 Ac 3+ is particularly potent because of the yield of 4 α particles in the decay pathway to 209 Bi. Traditional radiometal-labeling requires the use of bifunctional chelates, such as DOTA or diethylenetriaminepentaacetic acid, to bind the free metal radionuclides to the targeting ligand. Recently, chelates have been used to attach 225 Ac 3+ to ammonium functionalized carbon nanotubes for therapy of model human lymphoma (16) . Although these macrocyclic chelates have provided several clinical successes, typically less than 1 chelated α-emitting atom is attached for every 100-1,000 targeting ligands, suggesting an ongoing need to identify alternative chelating agents. The use of selective targeting agents, such as monoclonal antibodies, for the delivery of therapeutics to specific sites in vivo may decrease radioimmunotherapy toxicity (13) . There is an inherent preference for intracellular uptake and retention of radio-metals over radiohalides (17) , and US-tubes are also inherently bioinert, intracellular agents (18, 19) . Another potential radioimmunotherapy agent, 211 At, has been previously reported to be encapsulated within US-tubes by oxidation to form the mixed halide 211 AtCl 2 (8) . However, 211 At possesses a short half-life (7.21 h) compared with 225 Ac 3+ (10 d) , making the 225 Ac 3+ approach more practical. The successful targeting of a 225 Ac 3+ /US-tube construct could lead to rapid uptake of 225 Ac 3+ within targeted diseased cells. In this article, we report a new synthetic approach to the internalization and stable retention of 225 Ac 3+ ions within US-tubes (accomplished through the addition of Gd 3+ ions) as displayed in Figure 2 .
MATERIALS AND METHODS

Ac 3+
A dried 225 AcNO 3 residue obtained from the Department of Energy (Oak Ridge National Laboratory) was dissolved in 0.1 mL of 0.2 M HCl (Optima grade; Fisher Scientific). 225 Ac activity was measured using a drop well dose calibrator (CRC-17 radioisotope calibrator; E.R. Squibb and Sons, Inc.) set at 775, with displayed activity value multiplied by 5.
US-Tube Synthesis
US-tubes were prepared following a previously established synthetic method ( Fig. 1) (6) . Briefly, 1.0 g of full-length SWNTs produced in an electric arc discharge with nickelyttrium catalyst (AP grade; CarboLex, Inc.) (Fig. 1A ) was exposed to a fluorinating gas mixture (5.2% helium-diluted F 2 ) at 125°C for 12 h. The resulting fluorinated SWNTs were pyrolyzed at 1,000°C for 2 h under argon gas, rendering ultrashort nanotubes (US-tubes), 20-80 nm in length, with sidewall defects that facilitate the aqueous internal loading of ions ( Fig. 1B) (7) (8) (9) . The US-tubes were then purified of nickel-yttrium catalyst impurities via bath sonication in concentrated HCl and chemically reduced in an amended Birch reduction with potassium in anhydrous tetrahydrofuran (3). The reduction yields individualized UStubes as opposed to small bundles of US-tubes (Fig. 1C) .
225 Ac 3+ Labeling US-tubes were dispersed via bath sonication to a concentration of 5 g/L in metal-free water obtained from a Purelab Plus system (United States Filter Corp.). Three separate aqueous loading techniques were examined: the first was addition of 225 Ac 3+ ions alone, the second was addition of a mixture of Gd 3+ ions and 225 Ac 3+ ions, and the third was sequential addition of Gd 3+ ions followed by 225 Ac 3+ ions. For 225 Ac 3+ ions alone, 3.0 μL of 225 AcCl 3 (7.0 MBq) were diluted in 200 μL of metal-free water and mixed with 50 μL of US-tube suspension. For the mixture, 3 μL of 225 AcCl 3 (7.0 MBq) were diluted in 150 μL of metalfree water, mixed with 50 μL of 19 mM GdCl 3 (Aldrich Chemical) and 50 μL of the US-tube suspension. Finally, for the sequential addition, 150 μL of metal-free water were mixed with 50 μL of 19 mM GdCl 3 and 50 μL of the US-tube suspension (the previously established method for creation of the gadonanotubes); after 24 h, 7.0 MBq of 225 AcCl 3 were added to the GdCl 3 /US-tube solution. Activity was determined using a Cobra γ counter (Packard Instrument Co., Inc.) with a 340-to 540-keV window.
Previous work detailing the loading of Gd 3+ into US-tubes produced the desired product by 1 h of bath sonication followed by overnight equilibration (9) . To help ensure that 225 Ac could be encapsulated, samples were bath-sonicated for 2 h and allowed to equilibrate overnight. The next day, all samples were washed with 250 μL of metal-free water and filtered using a Handee Micro-Spin Column (Thermo Scientific Pierce) with a paper membrane (pore size, ~10 μm) until no activity was detected in the filtrate via drop well dose calibrator. After filtration, all samples were resuspended in 200 μL of distilled water by pipette aspiration and the activity measured. All loading procedures were performed in triplicate.
Human Serum Challenge Experiments
To simulate in vivo conditions, challenge experiments were conducted monitoring the effect of heat, time, or human serum on 225 Ac@US-tube suspensions. For each serum challenge, 20 μL of the resulting 225 Ac@US-tube (12.5 μg) suspension from the above 3 loading techniques were added to 180 μL of normal human AB serum (Sigma Chemical Co.). The mixture was then stirred and incubated at 37°C for 2 h. After incubation, the mixture was filtered using a centrifugal device (100g, 5 min.), and the serum filtrate was counted in scintillation fluid using a β counter (samples were allowed to reach equilibrium overnight).
Standards of 225 Ac@gadonanotubes ( 225 Ac@GNTs) (prepared by the second technique above) were counted as a reference. For rechallenging the samples, 200 μL of serum were again added to the filter device, and the mixture was resuspended and reincubated at 37°C for 2 h. The filtration process was repeated. As a control, 225 AcCl 3 alone in serum was spun in the filter device. Samples also were challenged for longer times (4 and 12 h) and at both room temperature and 37°C to compare the effects of temperature and time in serum.
RESULTS
Ac 3+ Labeling
Serial washings via centrifuge filtration were used to determine the extent of 225 Ac 3+ labeling. For the loading protocol involving only 225 Ac 3+ , over 95% (6.7 MBq) of the initial activity remained with the US-tubes after washing. For both loading techniques involving Gd 3+ ions with 225 Ac 3+ ions (simultaneous and sequential), only 50% (3.5 MBq) of the initial activity remained associated with the US-tubes. This reduction in yield is likely due to the large excess of Gd 3+ ions saturating potential binding sites for 225 Ac at the US-tube sidewall defects. All 3 loading techniques ( 225 Ac 3+ only, 225 Ac 3+ and Gd 3+ simultaneously, and 225 Ac 3+ and Gd 3+ sequentially) showed no radioactivity in the centrifugal filtrate after the third washing of 250 μL, implying that only 750 μL of metal-free water was required to separate the 225 Ac 3+ ions not bound by the US-tubes in suspension.
Human Serum Challenge Experiments
The 225 Ac@US-tubes and 225 Ac@GNTs were challenged with human serum (Fig. 3) . For the 225 Ac@US-tubes labeled with only 225 Ac 3+ ions, only 40.0% (2.7 MBq) of the loaded 225 Ac 3+ remained after the initial human AB serum washing. There was little difference in 225 Ac 3+ retention after serum challenge of the US-tubes loaded via sequential and simultaneous techniques with 225 Ac 3+ and Gd 3+ ions within the US-tubes. The simultaneous loading technique retained 77% (2.7 MBq), and the sequential technique retained 80% (2.8 MBq) (Fig. 3A) . Subsequent serum challenges of the 225 Ac@US-tubes loaded with Gd 3+ ions had no measurable effect on removing 225 Ac; however, subsequent challenges of the 225 Ac@US-tubes with no Gd 3+ ions present continued to further remove 225 Ac, until less than 5.0% (0.34 MBq) of the original 225 Ac activity remained bound by the US-tubes. Conversely, subsequent challenges of the 225 Ac@GNTs (after the initial ~20% activity loss) through both simultaneous and sequential loading revealed no measurable quantity of 225 Ac 3+ in the filtrate and approximately 100% retention of the remaining 225 Ac 3+ ions with the 225 Ac@GNTs in the filter (Fig. 3B) . Moreover, the additional challenges of time (both 4 and 12 h) and elevated temperature (37°C) of the 225 Ac@GNTs using the simultaneous loading technique did not produce additional losses of 225 Ac 3+ (Fig. 3C) . Control experiments (free 225 AcCl in serum) showed no significant nonspecific retention of 225 Ac 3+ on the filter devices. These results indicate that a serum challenge may be used as a stripping procedure to purify the material by removing loosely bound 225 Ac 3+ ions that are not embedded within Gd 3+ ion clusters and encapsulated within the nanotube, as reported previously for US-tubes filled with 64 Cu (20) .
DISCUSSION
Previous work has shown that 225 Ac may be attached to carbon nanotubes by chelation with the macrocyclic chelator DOTA, which may be covalently linked to the external sidewall of the nanotube (16) . In the same manner, antibodies may be attached for in vivo targeting of the construct (12, 21) . In demonstrating that 225 Ac may be encapsulated within carbon nanotubes, we have simplified the production of these targeted nanoconstructs by eliminating the need for attachment of the macrocyclic chelator. Retention of the radioisotope within the nanotube reduces exposure to serum proteins and increases the area on the external sidewall that may be used for attaching targeting peptides or antibodies while retaining the therapeutic efficacy. Furthermore, the encapsulation of gadolinium within the carbon nanotubes has previously been shown to enhance MR imaging contrast (22) , and a bimodal PET/MR contrast agent has been produced by trapping 64 Cu 2+ within Gd 3+ clusters (20) .
The above results are consistent with the hypothesis that the 225 Ac 3+ ions should behave similarly to the Gd 3+ ions within US-tubes because of the similar solution chemistries of trivalent actinide ions and trivalent lanthanide ions (19) . One exception was the continual leakage of 225 Ac 3+ ions from the US-tubes for the 225 Ac@US-tubes on repetitive serum challenges, whereas Gd 3+ ions show no leakage (23) . Therefore, it is unclear whether the internalization of the 225 Ac 3+ ions directly mimics the Gd 3+ ion internalization of the gadonanotubes. Previous high-resolution transmission electron microscopy images revealed that the Gd 3+ ions in the gadonanotubes exist in small (1 nm × 2-5 nm) clusters that correspond to roughly 5-10 Gd 3+ ions per cluster (9); additionally, the gadonanotubes average 2%-5% Gd 3+ by mass as determined by inductively coupled plasma optical emission spectrometry. Assuming a mean length of 50 nm and approximately 120 carbon atoms per nanometer, each US-tube therefore contains about 10-20 Gd 3+ ions. Although the synthetic method herein uses the minimum concentration of US-tubes that can be reliably manipulated for filtration experiments, practical considerations (i.e., amount of radionuclide readily available) limited the concentration of 225 Ac 3+ ions such that the conditions provided for one 225 Ac 3+ ion for roughly every 250 US-tubes. At this low concentration, there are not enough 225 Ac 3+ ions present to form 225 Ac 3+ clusters that would directly mimic the stable Gd 3+ ion clusters inside the gadonanotubes. However, at this concentration, the 225 Ac 3+ ions behave similarly to the Gd 3+ ions when admixed into the US-tubes with Gd 3+ carrier ions, allowing for use of the nonradioactive ions for most of the cluster formation. Interestingly, the methodology of loading (sequential vs. simultaneous) appears to have little or no effect on the final product. This result should prove beneficial to future synthetic routes with regard to the time of production of 225 Ac 3+ /gadonanotube conjugates, and the solution chemistry of the 225 Ac 3+ ions within the gadonanotubes further supports the idea that production of an ion cluster is critical for their stable embedment within the US-tubes and their resistance to serum challenge. carbon nanotubes may also be used to encapsulate elements for imaging by MR or PET and may be functionalized with antibodies, creating a single construct capable of targeted imaging and therapy. Synthetic scheme for production of US-tubes. Representation of 225 Ac@GNT construct. Green represents Gd 3+ ions, yellow with radioactive symbol represents 225 Ac 3+ ion, and orange and yellow cluster represents emitted α particle. 
